• Prediagnostic Proinflammatory Dietary Potential Is Associated with All-Cause Mortality among African-American Women with High-Grade Serous Ovarian Carcinoma. (musc.edu)
  • in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study. (musc.edu)
  • Definitive radiotherapy for medically inoperable early-stage serous and clear cell uterine carcinoma. (musc.edu)
  • Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. (musc.edu)
  • There are five subtypes of ovarian carcinoma that are sufficiently distinct and well-characterized that they should be considered to be different diseases, i.e. high-grade serous, clear cell, endometrioid, mucinous and low-grade serous, from most to least common, respectively. (nih.gov)
  • To determine whether hormonal therapies have efficacy in patients with recurrent low-grade serous carcinoma of the ovary or peritoneum. (nih.gov)
  • We searched departmental databases for patients with histologically-confirmed, evaluable, recurrent low-grade serous ovarian or peritoneal carcinoma who received hormonal therapy at our institution between 1989 and 2009. (nih.gov)
  • We identified 64 patients with recurrent low-grade serous carcinoma of the ovary or peritoneum. (nih.gov)
  • Hormonal therapies have moderate anti-tumor activity in patients with recurrent low-grade serous carcinoma of the ovary or peritoneum. (nih.gov)
  • 3. Malignant transformation of a serous borderline tumor and early metastasis of associated low-grade serous carcinoma detected on screening mammography. (nih.gov)
  • 8. Application of real-time ultrasound elastography for discrimination of low- and high-grade serous ovarian carcinoma. (nih.gov)
  • 10. Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: A reappraisal. (nih.gov)
  • 13. The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor. (nih.gov)
  • 15. Low grade serous ovarian carcinoma: identifying variations in practice patterns. (nih.gov)
  • 17. Osseous Metaplasia in Low-grade Ovarian Serous Carcinoma With a BRAF Mutation: A Case Report. (nih.gov)
  • Consequently, TAG-72 was useful for the detection of ovarian carcinoma, especially for monitoring mucinous cystadenocarcinoma, and it is localized in the microvilli and apical cytoplasmic membrane of cystadenocarcinoma cells. (nih.gov)
  • The role of beta-catenin and cyclinD1 in diagnosis and prognosis of ovarian serous carcinoma is uncertain. (omeka.net)
  • One GEM contains gene expression profiles for GBM, lower grade glioma (LGG), bladder urothelial carcinoma (BLCA), thyroid carcinoma (THCA), and ovarian serous cystadenocarcinoma (OV) from TCGA [ 7 ] and is fully described in another publication [ 8 ]. (oncotarget.com)
  • Rare pancreatic tumors including acinar cell carcinoma, mucinous cystadenocarcinoma or serous cystadenocarcinoma. (uci.edu)
  • This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. (mountsinai.org)
  • 5. A case of bilateral ovarian synchronous tumors (left ovarian serous papillary adenocarcinoma and right ovarian malignant mixed Müllerian tumor). (nih.gov)
  • 9. Serous adenocarcinoma of the ovary diagnosed during ultrasound evaluation for fertility preservation. (nih.gov)
  • UNLABELLED: Ovarian serous cancer is the most common subtype of epithelial ovarian cancer, and is the leading cause of death from gynecologic cancer. (omeka.net)
  • Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES). (musc.edu)
  • 19. [Expression and clinicopathologic significance of CD44v6/CD24 in ovarian serous carcinomas]. (nih.gov)
  • Overexpression of beta-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas. (omeka.net)
  • In the present study, the expression of beta-catenin and cyclinD1 was examined in 60 ovarian serous carcinomas patients with immunohistochemical staining. (omeka.net)
  • 2. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors. (nih.gov)
  • 14. [Recent advances in studies of ovarian serous and mucinous borderline ovarien tumors]. (nih.gov)
  • This study analyzed the expression of TIMP-1,-2,-3 and the associated MMPs (MMP-2,-9,-11,-14) in different Stages, Grades and World Health Organization (WHO) classifications of serous ovarian tumors, ascites, ascites-derived cells from chemo-naïve (CN) and relapsed (CR) patients, and in ovarian cancer cell lines. (frontiersin.org)
  • TIMPs and related MMPs are differentially expressed in serous ovarian tumors, ascites, ascites-derived cells and ovarian cancer cell lines. (frontiersin.org)
  • 4. Ultrasound-Guided Laparoscopic Ovarian Wedge Resection in Recurrent Serous Borderline Ovarian Tumours. (nih.gov)
  • Cystadenocarcinoma, Serous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (musc.edu)
  • Also, histological localization of TAG-72 in the microvilli and apical cytoplasmic membrane was demonstrated by electron microscopy using MAb B72.3 and samples of seromucinous cystadenocarcinoma (mixed type). (nih.gov)
  • This graph shows the total number of publications written about "Cystadenocarcinoma, Serous" by people in this website by year, and whether "Cystadenocarcinoma, Serous" was a major or minor topic of these publications. (musc.edu)
  • 1. Management of low-grade serous ovarian neoplasm in the setting of fertility preservation. (nih.gov)
  • 18. High-Grade Serous Ovarian Cancer: Use of Machine Learning to Predict Abdominopelvic Recurrence on CT on the Basis of Serial Cancer Antigen 125 Levels. (nih.gov)
  • Is Trametinib a New Standard for Low-Grade Serous Ovarian Cancer? (medscape.com)